Bill > HR4191

This bill, known as the Mapping America's Pharmaceutical Supply (MAPS) Act, aims to improve the United States' preparedness and resilience in pharmaceutical supply chains by establishing a comprehensive strategy to identify and mitigate potential health and national security risks. The bill requires the Secretary of Health and Human Services to develop and regularly update an Essential Medicines List that includes critical drugs and pharmaceutical ingredients related to emergency response, high-risk shortage medications, and drugs essential for chronic condition treatment. The legislation mandates a detailed risk assessment of these essential medicine supply chains, examining factors such as foreign production dependencies, domestic manufacturing capabilities, and potential national security vulnerabilities. Additionally, the bill establishes a mapping and monitoring system that will use data analytics to visualize pharmaceutical supply chains from raw material production to final drug distribution, with the goal of identifying potential disruption risks. The Secretary must submit annual reports to Congress detailing the findings of these assessments and mapping efforts, and the bill includes provisions to protect confidential commercial information and ensure robust cybersecurity measures are in place during information sharing. By creating this comprehensive framework, the legislation seeks to enhance the United States' ability to anticipate, prevent, and respond to potential pharmaceutical supply chain challenges that could impact public health and national security.

Business and Industry

https://www.congress.gov/bill/119th-congress/house-bill/4191/all-info